Clinical Trials Directory

Trials / Completed

CompletedNCT00399568

Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery

Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel, Multiple-Dose Study of the Analgesic Efficacy and Safety of IV Acetaminophen (APAP) Versus Placebo Over 48 Hours(Hrs) for the Treatment of Postoperative Pain After Gynecologic Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
331 (actual)
Sponsor
Mallinckrodt · Industry
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study will be investigating the efficacy and safety administration of multiple doses of intravenous (IV) acetaminophen (IVAPAP) in the 48 hour period following Gynecologic Surgery.

Detailed description

The research hypothesis is that IV Acetaminophen will provide greater reduction in pain intensity and greater pain relief for moderate and severe pain as compared to placebo in the 48 hours following surgery.

Conditions

Interventions

TypeNameDescription
DRUGIV AcetaminophenIntravenous acetaminophen 1 g/100 mL
DRUGIV Placebo 100 mL solutionIV Placebo 100 mL solution dosed at same frequency as IV Acetaminophen every 6 hours (q6h)

Timeline

Start date
2006-11-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2006-11-15
Last updated
2016-10-21
Results posted
2010-12-10

Locations

27 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00399568. Inclusion in this directory is not an endorsement.